Skip to content
Menu

TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsDowngradesPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.

TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.

Read at benzinga.com

← All stock news